References
- WiedemannBSchoberEWaldhoerTIncidence of neonatal diabetes in Austria-calculation based on the Austrian Diabetes RegisterPediatr Diabetes2010111182319496964
- SlingerlandASShieldsBMFlanaganSEReferral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live birthsDiabetologia20095281683168519499210
- HattersleyATPearsonERMinireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetesEndocrinology200614762657266316556760
- ProksPAntcliffJFLippiatJGloynALHattersleyATAshcroftFMMolecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological featuresProc Natl Acad Sci U S A2004101175391754415583126
- StøyJEdghillELFlanaganSEInsulin gene mutations as a cause of permanent neonatal diabetesProc Natl Acad Sci U S A2007104150401504417855560
- ColomboCPorzioOLiuMSeven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitusJ Clin Invest20081182148215618451997
- NjølstadPRSovikOCuesta-MunozANeonatal diabetes mellitus due to complete glucokinase deficiencyN Eng J Med200134415881592
- NjølstadPRSagenJVBjorkhaugLPermanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathwayDiabetes2003522854286014578306
- EdghillELGloynALGorielyAOrigin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblingsJ Clin Endocrinol Metab2007921773177717327377
- GloynALCummingsEAEdghillELPermanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channelJ Clin Endocrinol Metab2004893932393515292329
- VaxillaireMPopulaireCBusiahKKir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patientsDiabetes2004532719272215448107
- GloynALSiddiquiJEllardSMutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinismHum Mutat20062722023116416420
- VaxillaireMDechaumeABusiahKNew ABCC8 mutations in relapsing neonatal diabetes and clinical featuresDiabetes2007561737174117389331
- BabenkoAPPolakMCaveHActivating mutations in the ABCC8 gene in neonatal diabetes mellitusN Engl J Med200635545646616885549
- ShieldJPFlanaganSEMackayDJMosaic paternal uniparental isodisomy and an ABCC8 gene mutation in a patient with permanent neonatal diabetes and hemihypertrophyDiabetes20085725525817942821
- AshcroftFMProksPSmithPAStimulus-secretion coupling in pancreatic β-cellsJ Cell Biochem199455Suppl54657929618
- ProksPGirardCHaiderSA gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndromeEMBO Rep2005647047515864298
- AshcroftFMRorsmanPElectrophysiology of the pancreatic beta-cellProg Biophys Mol Biol198954871432484976
- CookDLHalesCNIntracellular ATP directly blocks K+ channels in pancreatic B-cellsNature19843112712736090930
- AshcroftFMHarrisonDEAshcroftSJGlucose induces closure of single potassium channels in isolated rat pancreatic beta-cellsNature19843124464486095103
- AshcroftFMATP-sensitive K channels and disease: from molecule to maladyAm J Physiol Endocrinol Metab2007293880889
- AshcroftFMATP-sensitive potassium channelopathies: focus on insulin secretionJ Clin Invest20051152047205816075046
- SeinoSMikiTPhysiological and pathophysiological roles of ATP-sensitive K+ channelsProg Biophys Mol Biol20038113317612565699
- MikiTLissBMinamiKATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasisNat Neurosci2001450751211319559
- LiDPChenSRPanHLAdenosine inhibits paraventricular pre-sympathetic neurons through ATP-dependent potassium channelsJ Neurochem2010113253054220096091
- Bahi-BuissonNEisermannMNivotSInfantile spasms as an epileptic feature of DEND syndrome associated with an activating mutation in the potassium adenosine triphosphate (ATP) channel, Kir6.2J Child Neurol20072291147115017890419
- AmorosoSSchmid-AntomarchiHFossetMGlucose, sulfonylureas, and neurotransmitter release: role of ATP-sensitive K+ channelsScience19902478528542305257
- ShyngSNicholsCGOctameric stoichiometry of the KATP channel complexJ Gen Physiol19971106556649382894
- ClementJPKunjilwarKGonzalezGAssociation and stoichiometry of KATP channel subunitsNeuron1997188278389182806
- InagakiNGonoiTClementJPReconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptorScience1995270116611707502040
- SakuraHAmmalaCSmithPACloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscleFEBS Lett19953773383448549751
- InagakiNTsuuraYNambaNCloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heartJ Biol Chem1995270569156947890693
- ShiNQYeBMakielskiJCFunction and distribution of the SUR isoforms and splice variantsJ Mol Cell Cardiol200539516015978902
- Aguilar-BryanLNicholsCGWechslerSWCloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretionScience19952684234267716547
- ChutkowWASimonMCLe BeauMMCloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channelsDiabetes199645143914458826984
- IsomotoSKondoCYamadaMA novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channelJ Biol Chem199627124321243248798681
- SimJHYangDKKimYCATP-sensitive K+ channels composed of Kir6.1 and SUR2B subunits in guinea pig gastric myocytesAm J Physiol Gastrointest Liver Physiol2002282G137G14411751167
- AntcliffJFHaiderSProksPFunctional analysis of a structural model of the ATP-binding site of the KATP channel Kir6.2 subunitEMBO J20052422923915650751
- ProksPAshcroftFMModeling KATP channel gating and its regulationProg Biophys Mol Biol20099971918983870
- MasiaRKosterJCTuminiSAn ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetesDiabetes20075632833617259376
- AittoniemiJFotinouCCraigTJSUR1: a unique ATP-binding cassette protein that functions as an ion channel regulatorPhilos Trans R Soc Lond B Biol Sci2009364151425726718990670
- MikiTSeinoSRoles of KATP channels as metabolic sensors in acute metabolic changesJ Mol Cell Cardiol20053891792515910876
- NicholsCGShyngSLNestorowiczAAdenosine diphosphate as an intracellular regulator of insulin secretionScience1996272178517878650576
- GribbleFMTuckerSJAshcroftFMThe essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxideEMBO J199716114511529135131
- ZingmanLVAlekseevAEBienengraeberMSignaling in channel/enzyme multimers: ATPase transitions in SUR module gate ATP-sensitive K+ conductanceNeuron20013123324511502255
- MikhailovMVCampbellJDde WetH3-D structural and functional characterization of the purified KATP channel complex Kir6.2-SUR1EMBO J2005244166417516308567
- ZerangueNSchwappachBJanYNA new ER trafficking signal regulates the subunit stoichiometry of plasma membrane KATP channelsNeuron19992253754810197533
- BienengraeberMAlekseevAEAbrahamMRATPase activity of the sulfonylurea receptor: a catalytic function for the KATP channel complexFASEB J2000141943195211023978
- ThomasPMYeYLightnerEMutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancyHum Mol Genet19965180918128923010
- ThomasPMCoteGJWohllkNMutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancyScience19952684264297716548
- GloynALPearsonERAntcliffJActivating mutations in the gene encoding the ATP sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetesN Eng J Med200435018381849
- ColomboCDelvecchioMZecchinoCTransient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutationDiabetologia200548112439244116205880
- YorifujiTNagashimaKKurokawaKThe C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitusJ Clin Endocrinol Metab20059063174317815784703
- RiedelMJSteckleyDCLightPECurrent status of the E23K Kir6.2 polymorphism: implications for type-2 diabetesHum Genet2005116313314515565284
- TarasovAINicolsonTJRivelineJPA rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adultsDiabetes20085761595160418346985
- DunneMJCosgroveKEShepherdRMHyperinsulinism in infancy: from basic science to clinical diseasePhysiol Rev20048423927514715916
- DunneMJKaneCShepherdRMFamilial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptorN Engl J Med1997336107037069041101
- ShimomuraKFlanaganSEZadekBAdjacent mutations in the gating loop of Kir6.2 produce neonatal diabetes and hyperinsulinismEMBO Mol Med2009116617720049716
- GlaserBThorntonPOtonkoskiTGenetics of neonatal hyperinsulinismArch Dis Child200082F79F86
- FlanaganSEClauinSBellanne-ChantelotCUpdate of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinismHum Mutat20093017018018767144
- TaschenbergerGMougeyAShenSIdentification of a familial hyperinsulinism causing mutation in the sulfonylurea receptor 1 that prevents normal trafficking and function of KATP channelsJ Biol Chem2002277171391714611867634
- PartridgeCJBeechDJSivaprasadaraoAIdentification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulfonylurea receptor causing familial hyperinsulinismJ Biol Chem2001276359473595211457841
- YanFLinCWWeisigerESulfonylureas correct trafficking defects of ATP-sensitive potassium channels caused by mutations in the sulfonylurea receptorJ Biol Chem2004279110961110514707124
- HuopioHReimannFAshfieldRDominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1J Clin Invest200010689790611018078
- MatsuoMTrappSTanizawaYFunctional analysis of a mutant sulfonylurea receptor, SUR1–1420C, that is responsible for persistent hyperinsulinemic hypoglycemia of infancyJ Biol Chem2000275411844119110993895
- ShyngSLFerrigniTShepardJBFunctional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancyDiabetes199847114511519648840
- PinneySEMacMullenCBeckerSClinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutationsJ Clin Invest20081182877288618596924
- AmatoEDTammaroPCraigTJVariable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutationDiabet Med20082565165618544102
- ShimomuraKGirardCAProksPMutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effectsDiabetes2006551705171216731833
- GirardCShimomuraKProksPFunctional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetesPflugers Arch200645332333217021801
- TarasovAIGirardCALarkinBFunctional analysis of two K ir6. 2 (KCNJ11) mutations, K170T and E322K, causing neonatal diabetesDiabetes Obes Metab20079Suppl 2465517919178
- KlupaTEdghillELNazimJThe identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R201H mutationDiabetologia2005481029103115838686
- FlanaganSEEdghillELGloynALMutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotypeDiabetologia2006491190119716609879
- FlanaganSEPatchAMMackayDJMutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthoodDiabetes2007561930193717446535
- SlingerlandASHurkxWNoordamKSulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutationDiabet Med20082527728118307455
- DoyleDAMorais CabralJPfuetznerRAThe structure of the potassium channel: molecular basis of K+ conduction and selectivityScience199828069779525859
- HattersleyATAshcroftFMActivating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapyDiabetes2005542503251316123337
- ProksPGirardCBaevreHFunctional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapyDiabetes20065561731173716731836
- ReimannFTuckerSJProksPInvolvement of the N-terminus of Kir6.2 in coupling to the sulphonylurea receptorJ Physiol199951832533610381582
- BabenkoAPBryanJSUR-dependent modulation of KATP channels by an N-terminal Kir6.2 peptide: defining intersubunit gating interactionsJ Biol Chem2002277439974400412213829
- KosterJCKurataHTEnkvetchakulDA DEND mutation in Kir6.2 (KCNJ11) reveals a flexible N-terminal region critical for ATP-sensing of the KATP channelBiophys J2008954689469718708460
- ProksPGirardCAshcroftFMFunctional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by Mg-ATPHum Mol Genet2005142717272616087682
- TarasovAIWeltersHJSenkelSA Kir6.2 mutation causing neonatal diabetes impairs electrical activity and insulin secretion from INS-1 beta-cellsDiabetes2006553075308217065345
- MännikköRJefferiesCFlanaganSEInteraction between mutations in the slide helix of Kir6.2 associated with neonatal diabetes and neurological symptomsHum Mol Genet201019696397220022885
- GloynALReimannFGirardCRelapsing diabetes can result from moderately activating mutations in KCNJ11Hum Mol Genet20051492593415718250
- JohnSAWeissJNXieLHMolecular mechanism for ATP-dependent closure of the K+ channel Kir6.2J Physiol2003552233412860923
- ProksPArnoldALBruiningJA heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetesHum Mol Genet2006151793180016613899
- ProksPShimomuraKCraigTJMechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndromeHum Mol Genet2007162011201917584766
- FangKCsanadyLChaKWThe N-terminal transmembrane domain (TMD0) and a cytosolic linker (L0) of sulphonylurea receptor define the unique intrinsic gating of KATP channelsJ Physiol200657637938916887879
- MasiaRde LeonDDMacMullenCA mutation in the TMD0–L0 region of sulfonylurea receptor-1 (L225P) causes permanent neonatal diabetes mellitus (PNDM)Diabetes2007561357136217317760
- PatchAMFlanaganSEBoustredCMutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal periodDiabetes Obes Metab20079Suppl 2283917919176
- BabenkoAPBryanJSUR domains that associate with and gate KATP pores define a novel gatekeeperJ Biol Chem2003278415774158012941953
- TammaroPGirardCMolnesJKir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactionsEMBO J2005242318233015962003
- de WetHReesMGShimomuraKIncreased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetesProc Natl Acad Sci U S A2007104189881899218025464
- de WetHProksPLafondMA mutation (R826 W) in nucleotide-binding domain 1 of ABCC8 reduces ATPase activity and causes transient neonatal diabetesEMBO Rep2008964865418497752
- EllardSFlanaganSEGirardCAPermanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effectsAm J Hum Genet20078137538217668386
- MarkworthESchwanstecherCSchwanstecherMATP4–mediates closure of pancreatic beta-cell ATP-sensitive potassium channels by interaction with 1 of 4 identical sitesDiabetes2000491413141810969823
- HaniEHBoutinPDurandEMissense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of type II diabetes mellitus in CaucasiansDiabetologia199841151115159867219
- GloynALWeedonMNOwenKRLarge-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetesDiabetes20035256857212540637
- BarrosoILuanJMiddelbergRPCandidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin actionPLoS Biol20031E2014551916
- HammingKSSolimanDMatemiszLCCoexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K channelDiabetes2009582419242419587354
- SperlingMANeonatal diabetes mellitus: from understudy to center stageCurr Opin Pediatr200517451251816012265
- PolakMShieldJNeonatal and very-early-onset diabetes mellitusSemin Neonatol20049596515013476
- GreeleySATuckerSEWorrellHIUpdate in neonatal diabetesCurr Opin Endocrinol Diabetes Obes2010171131919952737
- SagenJVRaederHHathoutEPermanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapyDiabetes2004532713271815448106
- StanikJGasperikovaDPaskovaMPrevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriersJ Clin Endocrinol Metab2007921276128217213273
- UK Prospective Diabetes Study GroupIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)Lancet19983528378539742976
- The Diabetes Control and Complications Trial Research GroupThe effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitusN Eng J Med1993329977986
- WinklerMStephanDBiegerSTesting the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A B-site ligandsJ Pharmacol Exp Ther200732270170817495126
- AshcroftFMNew uses for old drugs: neonatal diabetes and sulphonylureasCell Metab20101117918120197050
- StoyJGreeleySAPazVPDiagnosis and treatment of neonatal diabetes: an United States experiencePediatr Diabetes2008945045918662362
- ProksPReimannFGreenNSulfonylurea stimulation of insulin secretionDiabetes200251Suppl 3S368S37612475777
- ZungAGlaserBNimriRGlibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2J Clin Endocrinol Metab2004895504550715531505
- MannaTDBattistimCRadonskyVGlibenclamide unresponsiveness in a brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) geneArq Bras Endocrinol Metabol20085281350135519169493
- KosterJCRemediMSDaoCATP and sulfonylurea sensitivity of mutant ATP-sensitive K channels in neonatal diabetes: implications for pharmacogenomic therapyDiabetes2005542645265416123353
- PearsonERFlechtnerINjolstadPRSwitching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutationsN Eng J Med2006355467477
- ChenKWangRWenSYRelationship of P450 2C9 genetic polymorphisms in Chinese and the pharmacokinetics of tolbutamideJ Clin Pharm Ther200530324124915896241
- KirchheinerJRootsIGoldammerMEffect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevanceClin Pharmacokinet200544121209122516372821
- SuzukiKYanagawaTShibasakiTEffect of CYP2C9 genetic polymorphisms on the efficacy and pharmacokinetics of glimepiride in subjects with type 2 diabetesDiabetes Res Clin Pract200672214815416325295
- BeckerMLVisserLETrienekensPHCytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitusClin Pharmacol Ther200883228829217597710
- SlingerlandASNuboerRHadders-AlgraMImproved motor development and good long-term glycemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 geneDiabetologia2006492559256317047922
- MlynarskiWTarasovAGachASulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11Nat Clin Pract Neurol200731164064517982434
- KosterJCCadarioFPeruzziCThe G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapyJ Clin Endocrinol Metab2008931054106118073297
- TurkkahramanDBircanITribbleNDPermanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapyJ Pediatr200815312212618571549
- SøvikONjølstadPFøllingIHyperexcitability to sulphonylurea in MODY3Diabetologia19984156076089628283
- PearsonERLiddellWGShepherdMSensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1 alpha gene mutations: evidence for pharmacogenetics in diabetesDiabet Med200017754354510972586
- GribbleFMReimannFDifferential selectivity of insulin secret-agogues mechanisms, clinical implications, and drug interactionsJ Diabetes Complications200317Suppl 2111512623163
- GribbleFMReimannFSulphonylurea action revisited: the post-cloning eraDiabetologia20034687589112819907
- InagakiNGonoiTClementJPA family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channelsNeuron199616101110178630239
- GribbleFMTuckerSJSeinoSTissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channelsDiabetes1998479141214189726229
- GribbleFMAshcroftFMDifferential sensitivity of beta-cell and extrapancreatic K(ATP) channels to gliclazideDiabetologia199942784584810440127
- SongDKAshcroftFMGlimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channelsBr J Pharmacol2001133119319911325810
- MikiTMinamiKZhangLATP-sensitive potassium channels participate in glucose uptake in skeletal muscle and adipose tissueAm J Physiol Endocrinol Metab2002283E1178E118412388128
- ChutkowWASamuelVHansenPADisruption of SUR2-containing K(ATP) channels enhances insulin-stimulated glucose uptake in skeletal muscleProc Natl Acad Sci U S A200198117601176411562480
- SkupienJMaleckiMTMlynarskiWAssessment of insulin sensitivity in adults with permanent neonatal diabetes mellitus due to mutations in the KCNJ11 gene encoding Kir6.2Rev Diabet Stud200631172017491708
- MaleckiMTSkupienJKlupaTTransfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating mutations: evidence for improvement in insulin sensitivityDiabetes Care200730114714917192350
- TessierDDawsonKTétraultJPGlibenclamide vs gliclazide in type 2 diabetes of the elderlyDiabet Med199411109749807895463
- HattersleyABruiningJShieldJISPAD Clinical Practice Consensus Guidelines 2006–2007. The diagnosis and management of monogenic diabetes in childrenPediatr Diabetes20067635236017212604
- PunPClarkRWanKWNeonatal diabetes mellitus: the impact of molecular diagnosisNeoReviews2010116e306e310
- DiStefanoJKWatanabeRMPharmacogenetics of anti-diabetes drugsPharmaceuticals2010382610264620936101